About Prof. Dr. Reinhard E. Voll
- Prof. Dr. Reinhard E. Voll is a Rheumatologist with 27+ years of experience.
- He worked as the Board member for the Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg in 2010, and also headed the IZKF Young Investigator Group 2 at the University Hospital of the Friedrich-Alexander from 2003-2009.
- He completed his graduation from the University of Erlangen-Nuremberg in 1984 and later did his postdoctoral training, Max-Planck-Society, Clinical Research Units for Rheumatology at the University of Erlangen-Nürnberg, Germany.
- He has been awarded a postdoctoral fellowship of the DFG at Howard Hughes Medical Institute, Yale University, School of Medicine, New Haven, the USA in 1996.
- He has worked on several research projects and has nearly 200+ publications,
Location
Graduation, University of Erlangen-Nuremberg(1984)- Fellowship, Fellowship, Yale University, School of Medicine, New Haven, CT, USA(1996)
- Senior Consultant, University Hospital Erlangen
Papers Published
- Alexander T, Sarfert R, Hiepe F, Voll RE. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus. Ann Rheum Dis. 2015; 74(7):1474-8.
+ Read More- Show Less
- Sehnert B, Burkhardt H, Wessels JT, Schröder A, May MJ, Vestweber D, Zwerina J, Warnatz K, Nimmerjahn F, Schett G, Dübel S, Voll RE. NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases. Proc Natl Acad Sci USA. 2013; 110(41):16556-16561.
- Fürnrohr BG, Wach S, Harley JB, Voll RE. Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus. Ann Rheum Dis. 2010; 69(11):1983-9.
- Urbonaviciute V, Fürnrohr BG, Herrmann M, Voll RE. Induction of infl ammatory and immune responses by HMGB1-nucleosome complexes – implications for the pathogenesis of SLE; J Exp Med. 2008; 205(13):3007-18.
- Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA, Voll RE. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med. 2008; 14(7):748-55.
Send Your Enquiry
Send Your EnquiryFill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
FAQ's About Prof. Dr. Reinhard E. Voll
Where does Prof. Dr. Reinhard E. Voll practice?
Prof. Dr. Reinhard E. Voll practices at Freiburg University Hospital, Freiburg
What is the specialty of Prof. Dr. Reinhard E. Voll?
Prof. Dr. Reinhard E. Voll specialty is Paediatric Rheumatologist
What is the experience of Prof. Dr. Reinhard E. Voll?
Prof. Dr. Reinhard E. Voll is Paediatric Rheumatologist with 31 years of experience.
Chat